Sublingual nitroglycerin-potentiated head-up tilt testing effectively unmasked neurally mediated syncope in children, demonstrating a positive rate of 63% and a specificity of 86%.
Case-Control (n=193)
Does sublingual nitroglycerin-potentiated head-up tilt testing improve the diagnostic yield for unexplained syncope in children?
Sublingual nitroglycerin-potentiated tilt testing is an effective and safe method to unmask neurally mediated syncope in children, significantly increasing the diagnostic yield with acceptable specificity.
Tasa de eventos absoluta: 63% vs 14%
AIMS: The aim of this prospective study was to assess the diagnostic value of a sublingual nitroglycerin (NTG) potentiated head-up tilt (HUT) testing protocol in children with unexplained syncope. METHODS AND RESULTS: One hundred and sixty-four consecutive paediatric patients with syncope of unknown origin and no evidence of organic heart disease (115 female, mean age 13 +/- 3 years) and 29 control children underwent a sublingual NTG-potentiated tilt testing protocol. Paediatric patients and controls were tilted at 60 degrees for 20 min and, if no symptom occurred, for other 15 min after sublingual 400 mug spray NTG administration. During the drug-free phase of the test, 13 patients (8%) and no controls had a positive response. After drug administration, a positive response occurred in another 88 patients (55%) and in four controls (14%), whereas an exaggerated response was observed in nine patients (5%) and in four controls (14%). Thus, the positive rate and specificity of sublingual NTG HUT test in children were 63 and 86%, respectively. No relevant adverse events were observed during the test. CONCLUSION: Tilt testing potentiated with sublingual NTG has proved to be effective and safe in unmasking the neurally mediated origin of unexplained syncope in children. The NTG challenge greatly increased the positive rate of passive tilt, with a small decrease in specificity.
Foglia-Manzillo et al. (Wed,) conducted a case-control in Unexplained syncope (n=193). Sublingual nitroglycerin (NTG) potentiated head-up tilt (HUT) testing vs. Control children was evaluated on Positive response to tilt testing. Sublingual nitroglycerin-potentiated head-up tilt testing effectively unmasked neurally mediated syncope in children, demonstrating a positive rate of 63% and a specificity of 86%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: